Little Green Pharma (ASX:LGP) Other Stockholders Equity: A$0.00 Mil (As of Mar. 2026)


What is Little Green Pharma Other Stockholders Equity?

Little Green Pharma ASX:LGP +4.55% Other Stockholders Equity is A$0.00 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Little Green Pharma's Other Stockholders Equity for the quarter that ended in Mar. 2026 was A$0.00 Mil.

Little Green Pharma's quarterly Other Stockholders Equity stayed the same from Mar. 2025 (A$0.00 Mil) to Sep. 2025 (A$0.00 Mil) but then declined from Sep. 2025 (A$0.00 Mil) to Mar. 2026 (A$0.00 Mil).

Little Green Pharma's annual Other Stockholders Equity stayed the same from Mar. 2024 (A$0.00 Mil) to Mar. 2025 (A$0.00 Mil) but then declined from Mar. 2025 (A$0.00 Mil) to Mar. 2026 (A$0.00 Mil).

Little Green Pharma Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma Other Stockholders Equity Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 -0.00 0.00 0.00 0.00

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Little Green Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of A$0.00 Mil mean?
Little Green Pharma (ASX:LGP) has a Other Stockholders Equity of A$0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Little Green Pharma and its competitors.
Is Little Green Pharma's Other Stockholders Equity too high?
Little Green Pharma's current Other Stockholders Equity is A$0.00 Mil.
How does Little Green Pharma's Other Stockholders Equity compare to ZTS and UTHR?
Little Green Pharma's Other Stockholders Equity of A$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Little Green Pharma and its competitors. Little Green Pharma's current Other Stockholders Equity is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.07 — trading 59.4% below its estimated fair value. The current Other Stockholders Equity is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Other Stockholders Equity is A$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).